Respiratory Transition Without Continuous Positive Airway Pressure

February 25, 2026 updated by: Hackensack Meridian Health

Respiratory Transition Without Continuous Positive Airway Pressure in Term Infants With Mild Respiratory Distress: A Pilot Study

The primary aim of this research project is to determine if term neonates (37:0 to 41:6 weeks' gestational age) with mild respiratory distress can safely transition without continuous positive airway pressure (CPAP). The secondary aim is to determine the incidence of pneumothorax (PTX) for all term neonates assessed to have mild respiratory distress in the delivery room (DR).

Study Overview

Study Type

Interventional

Enrollment (Actual)

22

Phase

  • Early Phase 1

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • New Jersey
      • Hackensack, New Jersey, United States, 07601
        • Hackensack Univeristy Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Full term infants (37 weeks + 0days to 41 weeks +6days gestational age)
  • Born via scheduled c-sections without labor
  • Who develop mild respiratory distress, defined as nasal flaring or, intermittent grunting, and/or mild retractions and/or +/- mild tachypnea ( respiratory rate 61-90).

Exclusion Criteria:

  • Moderate to severe respiratory distress (continuous grunting, or moderate retractions or respiratory rate greater than 90 breaths per minute),
  • need for positive pressure ventilation (PPV) or advanced resuscitation in the first 5 minutes of life,
  • meconium stained amniotic fluid,
  • major congenital anomalies or chromosomal abnormalities.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Standard of care
Continuous positive airway pressure (CPAP) is administered for mild respiratory distress
CPAP administration as per standard of care
Experimental: Watchful waiting
Neonates with mild respiratory distress are observed for 20 minutes, and CPAP is administered at 25 minutes of life if respiratory distress continues or earlier if moderate to severe respiratory distress occurs
Allowing transition without CPAP administration was assessed at 25 minutes of life

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Need for CPAP use at 25 minutes of life
Time Frame: At 25 minutes post birth (after 20 minutes of observation)

Babies with mild respiratory distress will be observed for 20 minutes (randomized at 5 minutes of life) using a pulse oximeter (per institutional post-resuscitation care guidelines) and under the study team's direct observation.

The active cohort will not receive CPAP unless respiratory distress worsens.

At 25 minutes post birth (after 20 minutes of observation)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Prevalence of pneumothorax in neonates
Time Frame: Within 6 hours of life
Number of babies with pneumothorax in neonates as assessed by a chest ultrasound.
Within 6 hours of life
NICU (Neonatal Intensive Care Unit) admission during hospital stay
Time Frame: Hospital day (from birth to discharge)
Number of babies admitted to the NICU for respiratory distress during the initial hospital stay (on average, 1-4 days).
Hospital day (from birth to discharge)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Nicole Spillane, MD, Hackensack Meridian Health

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 11, 2023

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

December 1, 2026

Study Registration Dates

First Submitted

January 21, 2026

First Submitted That Met QC Criteria

January 29, 2026

First Posted (Actual)

February 5, 2026

Study Record Updates

Last Update Posted (Actual)

February 27, 2026

Last Update Submitted That Met QC Criteria

February 25, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Mild Respiratory Distress

Clinical Trials on CPAP

Subscribe